Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J FitzGerald

Showing results (111-120 of 271) with videos related to

Pageof 28
Sort By:
Journal of Food Protection|March 24, 2004
Inhibition of Bacillus subtilis and Listeria innocua by nisin in combination with some naturally occurring organic compoundsN A Olasupo, D J Fitzgerald, A Narbad, et al.
The Journal of Biological Chemistry|March 15, 1996
Ligand-toxin hybrids directed to the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein exhibit lower toxicity than native Pseudomonas exotoxinA G Zdanovsky, M V Zdanovskaia, D Strickland, et al.
Letters in Applied Microbiology|November 25, 2003
Activity of natural antimicrobial compounds against Escherichia coli and Salmonella enterica serovar TyphimuriumN A Olasupo, D J Fitzgerald, M J Gasson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1988
Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cellsC B Siegall, V K Chaudhary, D J FitzGerald, et al.
Cancer Research|June 1, 1991
Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40)L H Pai, M G Gallo, D J FitzGerald, et al.
Journal of Internal Medicine. Supplement|January 1, 1989
Fish oils in cardiovascular diseaseG A Fitzgerald, G Braden, D J Fitzgerald, et al.
Circulation|August 23, 2000
Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosisO Belton, D Byrne, D Kearney, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2000
Glycoprotein IIb/IIIa receptor number and occupancy during chronic administration of an oral antagonistM J Quinn, D Cox, J B Foley, et al.
International Journal of Cancer|March 17, 1999
Complete regression of human B-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4(dsFv)-PE38 at doses tolerated by cynomolgus monkeysR J Kreitman, Q C Wang, D J FitzGerald, et al.
Circulation|August 1, 1984
The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humansD J Fitzgerald, L Roy, R M Robertson, et al.
Pageof 28

Showing results (111-120 of 271) with videos related to

Sort By:
Pageof 28
Journal of Food Protection|March 24, 2004
Inhibition of Bacillus subtilis and Listeria innocua by nisin in combination with some naturally occurring organic compoundsN A Olasupo, D J Fitzgerald, A Narbad, et al.
The Journal of Biological Chemistry|March 15, 1996
Ligand-toxin hybrids directed to the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein exhibit lower toxicity than native Pseudomonas exotoxinA G Zdanovsky, M V Zdanovskaia, D Strickland, et al.
Letters in Applied Microbiology|November 25, 2003
Activity of natural antimicrobial compounds against Escherichia coli and Salmonella enterica serovar TyphimuriumN A Olasupo, D J Fitzgerald, M J Gasson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1988
Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cellsC B Siegall, V K Chaudhary, D J FitzGerald, et al.
Cancer Research|June 1, 1991
Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40)L H Pai, M G Gallo, D J FitzGerald, et al.
Journal of Internal Medicine. Supplement|January 1, 1989
Fish oils in cardiovascular diseaseG A Fitzgerald, G Braden, D J Fitzgerald, et al.
Circulation|August 23, 2000
Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosisO Belton, D Byrne, D Kearney, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2000
Glycoprotein IIb/IIIa receptor number and occupancy during chronic administration of an oral antagonistM J Quinn, D Cox, J B Foley, et al.
International Journal of Cancer|March 17, 1999
Complete regression of human B-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4(dsFv)-PE38 at doses tolerated by cynomolgus monkeysR J Kreitman, Q C Wang, D J FitzGerald, et al.
Circulation|August 1, 1984
The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humansD J Fitzgerald, L Roy, R M Robertson, et al.
Pageof 28